Top compounds associated with response to CDH18


Feature Type Standardized
Nominal ANOVA
mRNA etoposide GDSC1000 pan-cancer AAC -0.075 0.03
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.065 0.03
mRNA CIL41 CTRPv2 pan-cancer AAC -0.11 0.03
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC -0.067 0.03
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.04
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.04
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.071 0.04
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.067 0.04
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.07 0.04
Download CSV